Bausch Health Companies Inc. cash flow statement
In fiscal 2025, Bausch Health Companies Inc.'s operations generated $1.40bn of cash; it spent $397m on capital projects, leaving free cash flow of $1.00bn.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 361 | 263 | 640 | 657 | 1,042 | 2,312 | 2,257 | 2,087 | 2,290 | 1,501 | 1,501 | 1,111 | 1,426 | −728 | 1,032 | 1,597 | 1,400 | 2,209 |
| Depreciation and amortisation | 149 | 255 | 613 | 986 | 2,016 | 1,614 | 2,467 | 2,866 | 2,858 | 2,819 | 2,075 | 1,825 | 1,552 | 1,394 | 1,264 | 1,267 | 1,208 | 1,150 |
| Stock-based pay | 6 | 98 | 94 | 66 | 46 | 78 | 140 | 165 | 87 | 87 | 102 | 105 | 128 | 126 | 132 | 150 | 216 | 242 |
| Capital spending | 7 | 17 | 59 | 108 | 115 | 292 | 235 | 235 | 171 | 157 | 270 | 302 | 269 | 218 | 215 | 337 | 397 | 344 |
| Free cash flow | 353 | 246 | 582 | 549 | 927 | 2,020 | 2,022 | 1,852 | 2,119 | 1,344 | 1,231 | 809 | 1,157 | −946 | 817 | 1,260 | 1,003 | 1,865 |
| Free cash flow after stock pay | 348 | 148 | 488 | 483 | 881 | 1,942 | 1,882 | 1,687 | 2,032 | 1,257 | 1,129 | 704 | 1,029 | −1,072 | 685 | 1,110 | 787 | 1,623 |
| Dividends paid | 147 | 356 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share buybacks | — | 60 | 639 | 281 | 56 | 0 | 72 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Shares issued | — | — | 0 | 0 | 2,307 | 0 | 1,433 | 0 | 0 | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 601 | 211 | 289 | 405 | 495 | 230 | 670 | 814 |
| Depreciation and amortisation | 307 | 305 | 307 | 306 | 290 | 295 | 281 | 284 |
| Stock-based pay | 43 | 43 | 46 | 43 | 84 | 52 | 54 | 52 |
| Capital spending | 106 | 115 | 99 | 91 | 92 | 109 | 77 | 66 |
| Free cash flow | 495 | 96 | 190 | 314 | 403 | 121 | 593 | 748 |
| Free cash flow after stock pay | 452 | 53 | 144 | 271 | 319 | 69 | 539 | 696 |
Compare with peers
- Zoetis cash flow
- Haleon plc cash flow
- Viatris cash flow
- Universe Pharmaceuticals Inc cash flow
- Organon & Co. cash flow
Head to head: BHC vs ZTSBHC vs HLNBHC vs VTRSBHC vs UPC
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies